Armor Investment Advisors’s iShares US Medical Devices ETF IHI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $519K | Sell |
10,504
-5,246
| -33% | -$266K | 0.17% | 65 |
|
|
2026
Q1 | $840K | Sell |
15,750
-1,497
| -9% | -$87.9K | 0.3% | 55 |
|
|
2025
Q4 | $1.07M | Sell |
17,247
-3,063
| -15% | -$189K | 0.39% | 45 |
|
|
2025
Q3 | $1.22M | Sell |
20,310
-18,598
| -48% | -$1.14M | 0.39% | 50 |
|
|
2025
Q2 | $2.44M | Sell |
38,908
-981
| -2% | -$59K | 0.92% | 28 |
|
|
2025
Q1 | $2.4M | Buy |
39,889
+44
| +0.1% | +$2.73K | 0.99% | 25 |
|
|
2024
Q4 | $2.32M | Buy |
39,845
+631
| +2% | +$37.5K | 0.96% | 25 |
|
|
2024
Q3 | $2.32M | Buy |
39,214
+1,078
| +3% | +$61.6K | 0.96% | 26 |
|
|
2024
Q2 | $2.14M | Buy |
38,136
+279
| +0.7% | +$15.6K | 0.99% | 27 |
|
|
2024
Q1 | $2.22M | Sell |
37,857
-343
| -0.9% | -$19.4K | 1.07% | 27 |
|
|
2023
Q4 | $2.06M | Buy |
38,200
+1,116
| +3% | +$54.5K | 1.09% | 29 |
|
|
2023
Q3 | $1.8M | Buy |
37,084
+268
| +0.7% | +$14.2K | 1.07% | 29 |
|
|
2023
Q2 | $2.08M | Sell |
36,816
-972
| -3% | -$53.5K | 1.26% | 26 |
|
|
2023
Q1 | $2.04M | Buy |
37,788
+18
| +0% | +$958 | 1.17% | 27 |
|
|
2022
Q4 | $1.99M | Buy |
37,770
+638
| +2% | +$32.4K | 1.21% | 25 |
|
|
2022
Q3 | $1.75M | Buy |
37,132
+72
| +0.2% | +$3.74K | 1.19% | 28 |
|
|
2022
Q2 | $1.87M | Buy |
37,060
+695
| +2% | +$37.9K | 1.21% | 28 |
|
|
2022
Q1 | $2.22M | Buy |
36,365
+961
| +3% | +$57.3K | 1.25% | 25 |
|
|
2021
Q4 | $2.33M | Sell |
35,404
-466
| -1% | -$29.8K | 1.31% | 22 |
|
|
2021
Q3 | $2.25M | Sell |
35,870
-664
| -2% | -$42.4K | 1.41% | 20 |
|
|
2021
Q2 | $2.2M | Buy |
36,534
+102
| +0.3% | +$5.9K | 1.33% | 25 |
|
|
2021
Q1 | $2.01M | Sell |
36,432
-132
| -0.4% | -$7.32K | 1.3% | 25 |
|
|
2020
Q4 | $1.99M | Buy |
36,564
+6,714
| +22% | +$351K | 1.41% | 19 |
|
|
2020
Q3 | $1.49M | Sell |
29,850
-3,942
| -12% | -$191K | 1.28% | 28 |
|
|
2020
Q2 | $1.49M | Sell |
33,792
-414
| -1% | -$17.7K | 1.29% | 27 |
|
|
2020
Q1 | $1.28M | Sell |
34,206
-2,148
| -6% | -$90.4K | 1.31% | 25 |
|
|
2019
Q4 | $1.6M | Buy |
36,354
+516
| +1% | +$21.7K | 1.24% | 26 |
|
|
2019
Q3 | $1.48M | Buy |
35,838
+1,926
| +6% | +$78.8K | 1.21% | 27 |
|
|
2019
Q2 | $1.36M | Buy |
33,912
+966
| +3% | +$36.6K | 1.15% | 27 |
|
|
2019
Q1 | $1.27M | Buy |
32,946
+5,046
| +18% | +$183K | 1.1% | 30 |
|
|
2018
Q4 | $929K | Buy |
27,900
+1,920
| +7% | +$66.5K | 0.94% | 35 |
|
|
2018
Q3 | $985K | Buy |
25,980
+3,600
| +16% | +$128K | 0.88% | 36 |
|
|
2018
Q2 | $748K | Buy |
22,380
+13,380
| +149% | +$436K | 0.67% | 50 |
|
|
2018
Q1 | $278K | Buy |
9,000
+6,060
| +206% | +$187K | 0.25% | 81 |
|
|
2017
Q4 | $85K | Buy |
+2,940
| New | +$84.8K | 0.08% | 108 |
|
Other funds holding IHI
AAS
Armor Investment Advisors's IHI Position: Q2 2026 in Review
Armor Investment Advisors reduced its iShares US Medical Devices ETF (IHI) stake by 33% in Q2 2026, selling an estimated $266K and leaving 10,504 shares worth $519K. The position accounts for 0.17% of the portfolio, ranked #65.
Armor Investment Advisors first reported a position in IHI in Q4 2017 and has held it in 35 quarters since. The position peaked at $2.44M in Q2 2025. 503 funds tracked by Wall St. Rank hold IHI as of Q2 2026.
- Armor Investment Advisors held 10,504 shares of iShares US Medical Devices ETF worth $519K as of Q2 2026.
- Armor Investment Advisors sold 5,246 iShares US Medical Devices ETF shares in Q2 2026, an estimated $266K.
- iShares US Medical Devices ETF made up 0.17% of Armor Investment Advisors's portfolio in Q2 2026, its #65 holding.
- Armor Investment Advisors first reported a position in iShares US Medical Devices ETF in Q4 2017 and has held it in 35 quarters since.
- Armor Investment Advisors's iShares US Medical Devices ETF position peaked at $2.44M in Q2 2025.
- 503 funds tracked by Wall St. Rank held iShares US Medical Devices ETF as of Q2 2026.
Based on Armor Investment Advisors's 13F filing for Q2 2026, filed 4 Aug 2026.